-
Signature
-
/s/ Bruce Jacobs, as Attorney-in-Fact
-
Issuer symbol
-
KYMR
-
Transactions as of
-
08 Dec 2025
-
Net transactions value
-
-$8,709,000
-
Form type
-
4
-
Filing time
-
08 Dec 2025, 18:09:20 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Mainolfi Nello |
Chief Executive Officer, Director |
C/O KYMERA THERAPEUTICS, INC., 500 NORTH BEACON STREET, 4TH FLOOR, WATERTOWN |
/s/ Bruce Jacobs, as Attorney-in-Fact |
08 Dec 2025 |
0001821189 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
KYMR |
Common Stock |
Options Exercise |
$208,000 |
+100,000 |
+15% |
$2.08 |
760,482 |
08 Dec 2025 |
Direct |
F1 |
| transaction |
KYMR |
Common Stock |
Sale |
$8,917,000 |
-100,000 |
-13% |
$89.17 |
660,482 |
08 Dec 2025 |
Direct |
F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
KYMR |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-100,000 |
-25% |
$0.000000 |
305,559 |
08 Dec 2025 |
Common Stock |
100,000 |
$2.08 |
Direct |
F1, F2 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: